Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1985 | 12-1984 | 12-1983 | 12-1982 | 12-1981 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 406,100 | 445,300 | 491,000 | 303,754 | 43,490 |
| Marketable Securities | 0 | 0 | 0 | 0 | 219,205 |
| Receivables | 604,800 | 560,400 | 543,900 | 555,730 | 579,679 |
| Inventories | 694,200 | 630,200 | 628,000 | 658,309 | 679,229 |
| Other current assets | 235,100 | 191,600 | 167,200 | 162,712 | 143,772 |
| TOTAL | $1,940,200 | $1,827,500 | $1,830,100 | $1,680,505 | $1,665,375 |
| Non-Current Assets | |||||
| PPE Net | 1,374,000 | 1,280,400 | 1,212,600 | 1,135,575 | 1,006,180 |
| Investments And Advances | 262,000 | 192,000 | 114,300 | 103,800 | 113,200 |
| Other Non-Current Assets | 377,500 | 344,000 | 256,800 | 235,245 | 117,507 |
| TOTAL | $2,013,500 | $1,816,400 | $1,583,700 | $1,474,620 | $1,236,887 |
| Total Assets | $3,953,700 | $3,643,900 | $3,413,800 | $3,155,125 | $2,902,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 124,200 | 114,800 | 107,200 | 111,127 | 119,343 |
| Accrued Expenses | 165,900 | 135,600 | 132,100 | 116,593 | 127,133 |
| Other current liabilities | 288,700 | 252,000 | 291,500 | 298,793 | 258,710 |
| TOTAL | $1,045,800 | $1,067,200 | $988,300 | $873,650 | $817,785 |
| Non-Current Liabilities | |||||
| Long Term Debt | 238,600 | 116,600 | 90,700 | 49,397 | 53,803 |
| TOTAL | $520,200 | $355,500 | $304,500 | $226,015 | $196,217 |
| Total Liabilities | $1,566,000 | $1,422,700 | $1,292,800 | $1,099,665 | $1,014,002 |
| Shareholders' Equity | |||||
| Common Shares | 91,300 | 47,700 | 47,700 | 47,618 | 47,516 |
| Retained earnings | 2,740,600 | 2,497,000 | 2,227,600 | 1,979,774 | 1,765,314 |
| Other shareholders' equity | -118,400 | -156,200 | -113,800 | -84,440 | -45,481 |
| TOTAL | $2,387,700 | $2,221,200 | $2,121,000 | $2,055,460 | $1,888,260 |
| Total Liabilities And Equity | $3,953,700 | $3,643,900 | $3,413,800 | $3,155,125 | $2,902,262 |